Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes.

Teng, P-N; Wang, G; Hood, B L; Conrads, K A; Hamilton, C A; Maxwell, G L; Darcy, K M; Conrads, T P

Teng, P-N; Wang, G; Hood, B L; Conrads, K A; Hamilton, C A; Maxwell, G L; Darcy, K M; Conrads, T P.

Afiliación

Teng PN; Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA.
Wang G; Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA.
Hood BL; Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA.
Conrads KA; Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA.
Hamilton CA; 1] Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA [2] Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, 8901 Wisconsi
Maxwell GL; 1] Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA [2] Department of Obstetrics and Gynecology, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.
Darcy KM; Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA.
Conrads TP; Women's Health Integrated Research Center at Inova Health System, Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA 22003, USA.

Br J Cancer ; 110(1): 123-32, 2014 Jan 07.

Article en En | MEDLINE | ID: mdl-24178762

Asunto(s)

Biomarcadores de Tumor/sangre; Colágeno Tipo XI/sangre; Proteínas de Neoplasias/sangre; Neoplasias Glandulares y Epiteliales/sangre; Neoplasias Ováricas/sangre; Biomarcadores de Tumor/biosíntesis; Biomarcadores de Tumor/genética; Carcinoma Epitelial de Ovario; Línea Celular Tumoral; Cisplatino/farmacología; Colágeno Tipo XI/biosíntesis; Colágeno Tipo XI/genética; Medios de Cultivo; Supervivencia sin Enfermedad; Resistencia a Antineoplásicos; Femenino; Expresión Génica; Humanos; Proteínas de Neoplasias/biosíntesis; Proteínas de Neoplasias/genética; Proteínas de Neoplasias/metabolismo; Neoplasias Glandulares y Epiteliales/tratamiento farmacológico; Neoplasias Glandulares y Epiteliales/genética; Neoplasias Glandulares y Epiteliales/metabolismo; Neoplasias Ováricas/tratamiento farmacológico; Neoplasias Ováricas/genética; Neoplasias Ováricas/metabolismo; Proteómica; Tasa de Supervivencia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Biomarcadores de Tumor / Neoplasias Glandulares y Epiteliales / Colágeno Tipo XI / Proteínas de Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google